fbpx
GE Announces the Successful Completion of the Open Cycle of the Azito Phase IV Power Plant, Generating Approximately 8% of Ivory Coast Current Installed Electricity CapacityRead more Eco Atlantic Acquires Additional Participating Interest in Block 3B/4B Offshore South AfricaRead more Cellulant Recognised as a Leading Payment Platform Solutions Provider in Nigeria for its Tingg PlatformRead more Binance Signs Cristiano Ronaldo for Exclusive PartnershipRead more Human Rights Volunteer Roles to Return for FIFA World Cup QatarRead more Mayor Adams Assembles National Group of Experts to Discuss Recommendations Before White House Conference on Hunger, Nutrition, and HealthRead more White House ‘Social Media Summit’: No Facebook, No Twitter, No Transparency CopyRead more White House ‘Social Media Summit’: No Facebook, No Twitter, No TransparencyRead more White House ‘Social Media Summit’: No Facebook, No Twitter, No TransparencyRead more White House ‘Social Media Summit’: No Facebook, No Twitter, No TransparencyRead more

Bayer sells pest control unit for $2.6 bn

show caption
Bayer's debt has grown in recent years as it has been plagued by legal woes since it bought Monsanto in 2018./AFP
Print Friendly and PDF

Mar 10, 2022 - 09:13 AM

BERLIN, GERMANY — German chemicals and pharmaceuticals giant Bayer said Thursday it has agreed to sell its pest control unit to British private equity firm Cinven for $2.6 billion (2.4 billion euros).

Bayer had announced last year its intention to offload its US-based unit, Environmental Science Professional.

“This divestment represents a very attractive purchase price and allows us to focus on our core agricultural business,” said Rodrigo Santos, head of Bayer’s Crop Science division.

Environmental Science Professional offers solutions to control pests, diseases and weeds in non-agricultural areas, including professional pest management, forestry and gardens.

The subsidiary has 800 employees and operates in more than 100 countries, with 600 million euros in turnover.

Bayer said it expects the transaction to be completed in the second half of this year, with proceeds to be used to reduce the group’s net financial debt.

Bayer’s debt has grown in recent years as it has been plagued by legal woes since it bought Monsanto in 2018.

It has faced a flood of cases in US courts by cancer patients who say the glyphosate chemical in the Roundup weedkiller caused them to fall ill. Bayer rejects the accusations.

LMBCHEALTH.COM uses both Facebook and Disqus comment systems to make it easier for you to contribute. We encourage all readers to share their views on our articles and blog posts. All comments should be relevant to the topic. By posting, you agree to our Privacy Policy. We are committed to maintaining a lively but civil forum for discussion, so we ask you to avoid personal attacks, name-calling, foul language or other inappropriate behavior. Please keep your comments relevant and respectful. By leaving the ‘Post to Facebook’ box selected – when using Facebook comment system – your comment will be published to your Facebook profile in addition to the space below. If you encounter a comment that is abusive, click the “X” in the upper right corner of the Facebook comment box to report spam or abuse. You can also email us.